Antidepressant Prescribing Trends in Australia: A Growing Concern
The use of antidepressants in Australia has been on the rise, particularly among young people, according to a recent study. The research, conducted by the University of South Australia, analyzed dispensing data from the Pharmaceutical Benefits Scheme (PBS) between 2014 and 2023, covering over 300,000 antidepressant users.
The findings reveal a concerning trend: long-term antidepressant use has increased significantly, with 45% of young people on antidepressants staying on them for over 12 months, and many continuing their use for two years or more. This is a stark contrast to the recommended guidelines, which suggest a careful review of medication after 6-12 months.
The study's lead author, Dr. Lasantha Ranwala, highlights a critical issue: the prolonged use of antidepressants is not only becoming more common but also raises concerns about overprescribing. This is especially problematic for younger individuals, where psychological therapies are typically the recommended first-line treatment.
Between 2014 and 2022, long-term antidepressant use rose from 66 to nearly 85 users per 1000 people, before stabilizing in 2023. Women consistently demonstrated higher usage rates than men throughout the study period.
Dr. Ranwala emphasizes the potential risks of prolonged antidepressant use, including increased side effects and more challenging withdrawal processes. Misinterpreting withdrawal symptoms as a return of the underlying condition can lead to extended treatment periods, exacerbating the issue.
The study also found no significant improvements in weaning people off antidepressants. The proportion of long-term users who were placed on lower doses remained unchanged over the decade, at 17.9% in 2014 and 17.8% in 2023.
Several factors contribute to this trend, including a surge in mental health issues among young people, rising rates of psychological distress, the impact of the COVID-19 pandemic, and limited access to psychological therapies. The researchers advocate for a more balanced approach, ensuring appropriate antidepressant use and providing patients with adequate support to reduce or discontinue treatment when necessary.
To address this concern, the authors propose a stronger framework for safely tapering antidepressants and improved access to psychological care. Emerging technologies, such as predictive analytics and clinical decision-support tools, could assist clinicians in identifying appropriate times for deprescribing. However, stronger support systems are needed to ensure safe practices.
The study, 'Increasing Prevalence of Long-Term Antidepressant Use in Australia,' published in Pharmacoepidemiology and Drug Safety, emphasizes the urgent need for attention to this growing issue.
